loading…
J9218 Leuprolide acetate, per 1 mg
BackJ9000Injection, doxorubicin hydrochloride, 10 mg→J9003Leuprolide injectable (camcevi etm), 1 mg→J9011Injection, datopotamab deruxtecan-dlnk, 1 mg→J9015Injection, aldesleukin, per single use vial→J9017Injection, arsenic trioxide, 1 mg→J9021Injection, asparaginase, recombinant, (rylaze), 0.1 mg→J9022Injection, atezolizumab, 10 mg→J9023Injection, avelumab, 10 mg→J9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjs→J9025Injection, azacitidine, 1 mg→J9026Injection, tarlatamab-dlle, 1 mg→J9027Injection, clofarabine, 1 mg→J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram→J9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose→J9030Bcg live intravesical instillation, 1 mg→J9032Injection, belinostat, 10 mg→J9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mg→J9034Injection, bendamustine hcl (bendeka), 1 mg→J9035Injection, bevacizumab, 10 mg→J9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg→J9038Injection, axatilimab-csfr, 0.1 mg→J9039Injection, blinatumomab, 1 microgram→J9040Injection, bleomycin sulfate, 15 units→J9041Injection, bortezomib, 0.1 mg→J9042Injection, brentuximab vedotin, 1 mg→J9043Injection, cabazitaxel, 1 mg→J9045Injection, carboplatin, 50 mg→J9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg→J9047Injection, carfilzomib, 1 mg→J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg→J9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg→J9050Injection, carmustine, 100 mg→J9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg→J9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg→J9053Injection, belantamab mafodotin-blmf, 0.1 mg→J9054Injection, bortezomib (boruzu), 0.1 mg→J9055Injection, cetuximab, 10 mg→J9056Injection, bendamustine hydrochloride (vivimusta), 1 mg→J9057Injection, copanlisib, 1 mg→J9060Injection, cisplatin, powder or solution, 10 mg→J9061Injection, amivantamab-vmjw, 2 mg→J9062Injection, amivantamab 5 mg and hyaluronidase-lpuj→J9063Injection, mirvetuximab soravtansine-gynx, 1 mg→J9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg→J9065Injection, cladribine, per 1 mg→J9066Injection, bendamustine hydrochloride (avyxa), 1 mg→J9071Injection, cyclophosphamide (auromedics), 5 mg→J9072Injection, cyclophosphamide (frindovyx), 5 mg→J9073Injection, cyclophosphamide (dr. reddy's), 5 mg→J9074Injection, cyclophosphamide (sandoz), 5 mg→J9075Injection, cyclophosphamide, not otherwise specified, 5 mg→J9076Injection, cyclophosphamide (baxter), 5 mg→J9100Injection, cytarabine, 100 mg→J9118Injection, calaspargase pegol-mknl, 10 units→J9119Injection, cemiplimab-rwlc, 1 mg→J9120Injection, dactinomycin, 0.5 mg→J9130Dacarbazine, 100 mg→J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj→J9145Injection, daratumumab, 10 mg→J9150Injection, daunorubicin, 10 mg→J9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine→J9155Injection, degarelix, 1 mg→J9161Injection, denileukin diftitox-cxdl, 1 mcg→J9171Injection, docetaxel, 1 mg→J9172Injection, docetaxel (docivyx), 1 mg→J9173Injection, durvalumab, 10 mg→J9174Injection, docetaxel (beizray), 1 mg→J9175Injection, elliotts' b solution, 1 ml→J9176Injection, elotuzumab, 1 mg→J9177Injection, enfortumab vedotin-ejfv, 0.25 mg→J9178Injection, epirubicin hcl, 2 mg→J9179Injection, eribulin mesylate, 0.1 mg→J9183Gemcitabine intravesical system, 225 mg→J9184Injection, gemcitabine hydrochloride (avyxa), 200 mg→J9185Injection, fludarabine phosphate, 50 mg→J9186Injection, etoposide (avyxa), 1 mg→J9187Injection, etoposide, 1 mg→J9191Injection, fluorouracil (avyxa), 10 mg→J9192Injection, fluorouracil, 10 mg→J9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg→J9198Injection, gemcitabine hydrochloride, (infugem), 100 mg→J9200Injection, floxuridine, 500 mg→J9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg→J9202Goserelin acetate implant, per 3.6 mg→J9203Injection, gemtuzumab ozogamicin, 0.1 mg→J9204Injection, mogamulizumab-kpkc, 1 mg→J9205Injection, irinotecan liposome, 1 mg→J9206Injection, irinotecan, 20 mg→J9207Injection, ixabepilone, 1 mg→J9208Injection, ifosfamide, 1 gram→J9209Injection, mesna, 200 mg→J9210Injection, emapalumab-lzsg, 1 mg→J9211Injection, idarubicin hydrochloride, 5 mg→J9213Injection, interferon, alfa-2a, recombinant, 3 million units→J9214Injection, interferon, alfa-2b, recombinant, 1 million units→J9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu→J9216Injection, interferon, gamma 1-b, 3 million units→J9217Leuprolide acetate (for depot suspension), 7.5 mg→J9218Leuprolide acetate, per 1 mg→J9219Leuprolide acetate implant, 65 mg→J9220Injection, indigotindisulfonate sodium, 1 mg→J9223Injection, lurbinectedin, 0.1 mg→J9225Histrelin implant (vantas), 50 mg→J9226Histrelin implant (supprelin la), 50 mg→J9227Injection, isatuximab-irfc, 10 mg→J9228Injection, ipilimumab, 1 mg→J9229Injection, inotuzumab ozogamicin, 0.1 mg→J9230Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg→J9232Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg→J9245Injection, melphalan hydrochloride, not otherwise specified, 50 mg→J9246Injection, melphalan (evomela), 1 mg→J9248Injection, melphalan (hepzato), 1 mg→J9249Injection, melphalan (apotex), 1 mg→J9255Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg→J9256Injection, nipocalimab-aahu, 3 mg→J9260Injection, methotrexate sodium, 50 mg→J9261Injection, nelarabine, 50 mg→J9262Injection, omacetaxine mepesuccinate, 0.01 mg→J9263Injection, oxaliplatin, 0.5 mg→J9264Injection, paclitaxel protein-bound particles, 1 mg→J9266Injection, pegaspargase, per single dose vial→J9267Injection, paclitaxel, 1 mg→J9268Injection, pentostatin, 10 mg→J9269Injection, tagraxofusp-erzs, 10 micrograms→J9271Injection, pembrolizumab, 1 mg→J9272Injection, dostarlimab-gxly, 10 mg→J9273Injection, tisotumab vedotin-tftv, 1 mg→J9274Injection, tebentafusp-tebn, 1 microgram→J9275Injection, cosibelimab-ipdl, 2 mg→J9276Injection, zanidatamab-hrii, 2 mg→J9277Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph→J9278Injection, carboplatin (avyxa), 1 mg→J9280Injection, mitomycin, 5 mg→J9281Mitomycin pyelocalyceal instillation, 1 mg→J9282Mitomycin, intravesical instillation, 1 mg→J9285Injection, olaratumab, 10 mg→J9286Injection, glofitamab-gxbm, 2.5 mg→J9289Injection, nivolumab, 2 mg and hyaluronidase-nvhy→J9292Injection, pemetrexed dipotassium, 10 mg→J9293Injection, mitoxantrone hydrochloride, per 5 mg→J9294Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg→J9295Injection, necitumumab, 1 mg→J9296Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg→J9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg→J9298Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg→J9299Injection, nivolumab, 1 mg→J9301Injection, obinutuzumab, 10 mg→J9302Injection, ofatumumab, 10 mg→J9303Injection, panitumumab, 10 mg→J9304Injection, pemetrexed (pemfexy), 10 mg→J9305Injection, pemetrexed, not otherwise specified, 10 mg→J9306Injection, pertuzumab, 1 mg→J9307Injection, pralatrexate, 1 mg→J9308Injection, ramucirumab, 5 mg→J9309Injection, polatuzumab vedotin-piiq, 1 mg→J9311Injection, rituximab 10 mg and hyaluronidase→J9312Injection, rituximab, 10 mg→J9313Injection, moxetumomab pasudotox-tdfk, 0.01 mg→J9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg→J9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg→J9317Injection, sacituzumab govitecan-hziy, 2.5 mg→J9318Injection, romidepsin, non-lyophilized, 0.1 mg→J9319Injection, romidepsin, lyophilized, 0.1 mg→J9320Injection, streptozocin, 1 gram→J9321Injection, epcoritamab-bysp, 0.16 mg→J9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg→J9323Injection, pemetrexed ditromethamine, 10 mg→J9324Injection, pemetrexed (pemrydi rtu), 10 mg→J9325Injection, talimogene laherparepvec, per 1 million plaque forming units→J9326Injection, telisotuzumab vedotin-tllv, 1 mg→J9328Injection, temozolomide, 1 mg→J9329Injection, tislelizumab-jsgr, 1mg→J9330Injection, temsirolimus, 1 mg→J9331Injection, sirolimus protein-bound particles, 1 mg→J9332Injection, efgartigimod alfa-fcab, 2mg→J9333Injection, rozanolixizumab-noli, 1 mg→J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc→J9341Injection, thiotepa (tepylute), 1 mg→J9342Injection, thiotepa, not otherwise specified, 1 mg→J9345Injection, retifanlimab-dlwr, 1 mg→J9347Injection, tremelimumab-actl, 1 mg→J9348Injection, naxitamab-gqgk, 1 mg→J9349Injection, tafasitamab-cxix, 2 mg→J9350Injection, mosunetuzumab-axgb, 1 mg→J9351Injection, topotecan, 0.1 mg→J9353Injection, margetuximab-cmkb, 5 mg→J9354Injection, ado-trastuzumab emtansine, 1 mg→J9355Injection, trastuzumab, excludes biosimilar, 10 mg→J9356Injection, trastuzumab, 10 mg and hyaluronidase-oysk→J9357Injection, valrubicin, intravesical, 200 mg→J9358Injection, fam-trastuzumab deruxtecan-nxki, 1 mg→J9359Injection, loncastuximab tesirine-lpyl, 0.075 mg→J9360Injection, vinblastine sulfate, 1 mg→J9361Injection, efbemalenograstim alfa-vuxw, 0.5 mg→J9362Injection, trabectedin, 0.01 mg→J9370Vincristine sulfate, 1 mg→J9376Injection, pozelimab-bbfg, 1 mg→J9380Injection, teclistamab-cqyv, 0.5 mg→J9381Injection, teplizumab-mzwv, 5 mcg→J9382Injection, zenocutuzumab-zbco, 1 mg→J9390Injection, vinorelbine tartrate, 10 mg→J9393Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg→J9394Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg→J9395Injection, fulvestrant, 25 mg→J9400Injection, ziv-aflibercept, 1 mg→J9600Injection, porfimer sodium, 75 mg→J9601Injection, linvoseltamab-gcpt, 1 mg→J9999Not otherwise classified, antineoplastic drugs→
Procedure codeCODABLE
J9218
Leuprolide acetate, per 1 mg
CODING INFORMATION
CLAIMS SUBMITTED WITH THIS CODE (J9218) WITH OR WITHOUT A MULTIPLIER IN IN THE UNITS FIELD SHOULD BE REVIEWED IN TERMS OF THE POLICY PERTAINING TO SELF ADMINISTERED DRUGS.
- Part
- HCPCS Level II
- J
- Drugs Administered Other than Oral Method
- J9
- J9000–J9999
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.